NCT07358377
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07358377
Title A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Atridia Pty Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.